Early in the pandemic, the National Institutes of Health launched a response against the new virus that has expanded to include basic and clinical research, and research into vaccines and treatments. Dr. Emily Erbelding, director of the Division of Microbiology and Infectious Diseases, talks with Dr. Josh Sharfstein about NIH's role in supporting the scientific community, what treatments are currently gaining attention and scrutiny, and how the race to produce a vaccine needs multiple contenders.
